Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects

• Główni autorzy: Hong-Yu Luo (Autor), Shuo-Guo Xu (Autor), Li-Chen Gao (Autor), Hui-Zhi Long (Autor), Zi-Wei Zhou (Autor), Feng-Jiao Li (Autor), Shang-Ming Dai (Autor), Jin-Da Hu (Autor), Yu Su (Autor), Yan Cheng (Autor)
• Format: Książka
• Wydane: Adis, Springer Healthcare, 2024-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Potassium bismuth citrate is a gastric mucosal protector and a key drug for treating peptic ulcers. Objective To evaluate the pharmacokinetic characteristics and safety of 120-mg bismuth potassium citrate formulations administered orally under fasting conditions in healthy Chines...